Scandinavian ChemoTech AB (publ) (FRA:8V6)

Germany flag Germany · Delayed Price · Currency is EUR
0.287
-0.004 (-1.37%)
Last updated: Dec 5, 2025, 8:03 AM CET
178.64%
Market Cap 7.87M
Revenue (ttm) 1.06M
Net Income (ttm) -786.83K
Shares Out n/a
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 11
Open 0.287
Previous Close 0.291
Day's Range 0.287 - 0.287
52-Week Range 0.039 - 0.680
Beta n/a
RSI 38.93
Earnings Date Mar 3, 2026

About Scandinavian ChemoTech AB

Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden and Florida. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distributio... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2013
Employees 6
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8V6
Full Company Profile

Financial Performance

In 2024, Scandinavian ChemoTech AB's revenue was 6.57 million, an increase of 132.67% compared to the previous year's 2.82 million. Losses were -13.72 million, -34.96% less than in 2023.

Financial numbers in SEK Financial Statements

News

There is no news available yet.